NuScale Power Slips After UBS Cuts Price Target to $20

UBS flagged potential cash‑flow pressure tied to a major project for the pre‑revenue reactor developer.

Overview

NuScale shares fell about 6%–6.7% on Nov. 25 even as the S&P 500 and Nasdaq gained.
UBS analyst Jon Windham kept a Neutral rating and lowered his target from $38 to $20.
The report referenced NuScale’s third‑quarter results and payment timing related to ENTRA1 Energy’s work with the Tennessee Valley Authority.
The move extends a recent reversal for the stock following a prior target cut from Goldman Sachs after NuScale’s Q3 miss.
As a largely pre‑revenue SMR company with limited study-based income, NuScale faces heightened scrutiny over project execution, financing, and near‑term cash flow.